<DOC>
	<DOCNO>NCT02925624</DOCNO>
	<brief_summary>Title : CLOSE-guided pulmonary vein isolation ( PVI ) Cure Paroxysmal Atrial Fibrillation ( 'CLOSE CURE ' study ) Design : This prospective , observational , single-center , unblinded , clinical 3-year study . Background : In population paroxysmal atrial fibrillation ( AF ) 'CLOSE'-guided PVI , new approach obtain single-procedure durable PVI , show virtually eliminate recurrence AF 1 year follow-up repetitive discontinuous Holter monitoring . Objectives : ( 1 ) To objectively compare atrial tachyarrhythmia ( ATA ) burden 'CLOSE'-guided base PVI use continuous monitoring . ( 2 ) To assess ATA burden use continuous monitor 3 year ablation . ( 3 ) To identify baseline structural electrical property atria procedural characteristic predict 1-year 3-year outcome . Enrollment : Up 100 subject enrol observational , prospective study . Clinical Sites : 1 site . Subject Population : Eligible patient patient paroxysmal high-burden AF plan 'CLOSE'-guided PV isolation . At time procedural plan ask patient his/her consent ( 1 ) implantation subcutaneous continuous loop recorder ( sCLR ) , ( 2 ) concise electrophysiological study time PVI , ( 3 ) transthoracic echocardiogram time PVI ( 4 ) collection data 3 year . Anti-arrhythmic drug treatment ( ADT ) oral anticoagulation ( OAC ) give accord updated 2012 European society Cardiology ( ESC ) guideline AF ( Camm et al , European Heart Journal 2012 ) 2012 Heart rhythm society ( HRS ) /European Heart Rhythm association/European cardiac arrhythmic society Expert Consensus Statement catheter surgical ablation atrial fibrillation ( Calkins et al , Heart Rhythm 2012 ) .</brief_summary>
	<brief_title>CLOSE CURE Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patients symptomatic paroxysmal AF ( history selfterminating AF within 7 day history selfterminating AF 1 cardioversions within 48 hour onset ) , meet follow criterion outpatient clinic : patient least 3 AF episode last 3 month prior visit AF episode symptomatic , patient drugresistant ( least one class IC III ) , drugintolerant ( palpitation , fatigue , dyspnea , cardiomyopathy , â€¦ ) advance structural heart disease patient CHA2DS2VASc score 0 , 1 , 2 , 3 4 2 . Signed Patient Informed Consent Form . 3 . Age 18 year old . 4 . Able willing comply followup test requirement . 1 . Persistent atrial fibrillation ( history AF &gt; 7days history cardioversion &gt; 48h AF ) 2 . Previous ablation AF 3 . LA anteroposterior diameter &gt; 50 mm ( parasternal long axis view , PLAX ) 4 . LVEF &lt; 35 % ( ejection fraction ) 5 . AF secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause 6 . Coronary artery bypass grafting ( CABG ) procedure within last three month 7 . Awaiting cardiac transplantation cardiac surgery 8 . Documented leave atrial thrombus image 9 . Diagnosed atrial myxoma 10 . Women pregnant breastfeed 11 . Acute illness active systemic infection sepsis 12 . Unstable angina 13 . Uncontrolled heart failure 14 . Myocardial infarction within previous two month 15 . History blood clot bleed abnormality 16 . Contraindication anticoagulation therapy ( ie , heparin warfarin ) 17 . Life expectancy le 12 month 18 . Enrollment study evaluate another device drug 19 . Presence intramural thrombus , tumor abnormality precludes catheter introduction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ablation index</keyword>
	<keyword>pulmonary vein isolation</keyword>
	<keyword>implantable loop recorder</keyword>
</DOC>